Alignment Healthcare (ALHC) Cash & Equivalents (2021 - 2026)

Alignment Healthcare (ALHC) has 7 years of Cash & Equivalents data on file, last reported at $693.5 million in Q2 2026.

• Quarterly Cash & Equivalents rose 47.46% year-over-year to $693.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $693.5 million (up 47.46% YoY) and the FY2025 annual result came in at $575.8 million, up 33.03% from the prior year.
• Cash & Equivalents fell to $693.5 million in Q2 2026, from $705.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $705.6 million in Q1 2026 to a low of $202.9 million in Q4 2023.
• A 5-year average of $450.8 million and a median of $439.5 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2023 — Cash & Equivalents plunged 50.46% — and 2024, when it soared 113.33%.
• Tracing ALHC's Cash & Equivalents over 5 years: stood at $409.5 million in 2022, then sank by 50.46% to $202.9 million in 2023, then soared by 113.33% to $432.9 million in 2024, then surged by 33.03% to $575.8 million in 2025, then gained by 20.43% to $693.5 million in 2026.
• The last three Cash & Equivalents figures came in at $693.5 million (Q2 2026), $705.6 million (Q1 2026), and $575.8 million (Q4 2025), per Business Quant data.